Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 13:8:1927.
doi: 10.3389/fmicb.2017.01927. eCollection 2017.

An Update on Candida tropicalis Based on Basic and Clinical Approaches

Affiliations
Review

An Update on Candida tropicalis Based on Basic and Clinical Approaches

Diana L Zuza-Alves et al. Front Microbiol. .

Abstract

Candida tropicalis has emerged as one of the most important Candida species. It has been widely considered the second most virulent Candida species, only preceded by C. albicans. Besides, this species has been recognized as a very strong biofilm producer, surpassing C. albicans in most of the studies. In addition, it produces a wide range of other virulence factors, including: adhesion to buccal epithelial and endothelial cells; the secretion of lytic enzymes, such as proteinases, phospholipases, and hemolysins, bud-to-hyphae transition (also called morphogenesis) and the phenomenon called phenotypic switching. This is a species very closely related to C. albicans and has been easily identified with both phenotypic and molecular methods. In addition, no cryptic sibling species were yet described in the literature, what is contradictory to some other medically important Candida species. C. tropicalis is a clinically relevant species and may be the second or third etiological agent of candidemia, specifically in Latin American countries and Asia. Antifungal resistance to the azoles, polyenes, and echinocandins has already been described. Apart from all these characteristics, C. tropicalis has been considered an osmotolerant microorganism and this ability to survive to high salt concentration may be important for fungal persistence in saline environments. This physiological characteristic makes this species suitable for use in biotechnology processes. Here we describe an update of C. tropicalis, focusing on all these previously mentioned subjects.

Keywords: Candida tropicalis; antifungal resistance; phenotypic and molecular identification; update; virulence factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phenotypic characteristics of Candida tropicalis. (A) Cream-colored, dull, smooth colonies, after 48 h of incubation at 30°C on Sabouraud dextrose agar; (B) Colonies with typical dark blue color on CHROMagar Candida® medium after 96 h of incubation at 35°C; (C) Micromorphological aspects after incubation in YPD medium containing 20% fetal bovine serum (FBS) for 7 days at 30°C, 400x: blastoconidia in single or branched chains, true hyphae and abundant pseudohyphae.
Figure 2
Figure 2
Phylogenetic tree of Candida spp. internal transcribed spacer 1 (ITS1)-5.8S ribosomal RNA gene and internal transcribed spacer 2 (ITS2) complete sequences and their accession numbers, obtained from Genbank database at https://www.ncbi.nlm.nih.gov. Sequences were aligned using BioEdit software (v7.2.61). Aligned sequences were used for phylogenetic analysis conducted with Mega 7.0.26 Software. The method used for tree constructions was maximum parsimony. Phylogram stability was accessed by bootstrapping with 1,000 pseudoreplications.

References

    1. Adam B., Baillie G. S., Douglas L. J. (2002). Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J. Med. Microbiol. 51, 344–349. 10.1099/0022-1317-51-4-344 - DOI - PubMed
    1. Adhikary R., Joshi S. (2011). Species distribution and anti-fungal susceptibility of Candidaemia at a multi super-specialty center in Southern India. Indian J. Med. Microbiol. 29, 309–311. 10.4103/0255-0857.83920 - DOI - PubMed
    1. Aghamirian M. R., Ghiasian S. A. (2010). Onychomycosis in Iran: epidemiology, causative agents and clinical features. Nihon Ishinkin Gakkai Zasshi 51, 23–29. 10.3314/jjmm.51.23 - DOI - PubMed
    1. Al-Anazi K., Al-Jasser A. (2006). Candidaemia in patients with haematological disorders and stem cell transplant. Libyan J. Med. 1, 140–155. 10.3402/ljm.v1i2.4673 - DOI - PMC - PubMed
    1. Al-Araji L., Rahman R. N. Z. R. A., Basri M., Salleh A. B. (2007). Microbial surfactant. Asia Pac. J. Mol. Biol. Biotechnol. 15, 99–105.

LinkOut - more resources